HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography
March 12, 2024 09:00 ET
|
HeartFlow Holding, Inc.
HeartFlow's non-invasive AI driven FFRCT predicts patient outcomes as effectively as the gold-standard invasive FFR out to 10 years MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) --...
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
January 18, 2024 08:00 ET
|
Curonix LLC
Curonix Partners with Sure Med Compliance to Expand PNS Clinical Evidence
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
October 25, 2023 11:00 ET
|
HeartFlow Holding, Inc.
New Clinical Data Support Use of Lesion-Specific FFRCT for Diagnosis and Treatment of Patients With Coronary Artery Disease
Processa Pharmaceuticals To Present an Update on Its Future Therapeutic Focus and Strategy at the Biotech Showcase on January 11, 2023.
January 04, 2023 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), Dr. David Young, Processa Pharmaceuticals, CEO will present an update on Processa’s future therapeutic...
Processa Pharmaceuticals CEO Dr. David Young Issues Letter to Shareholders Providing Outlook for 2022
January 26, 2022 08:15 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical stage company developing drugs for patients who have unmet...
Real-World Evidence (RWE) Solutions Market Worth $4.4 Billion by 2028 - Exclusive Report by Meticulous Research®
November 17, 2021 10:45 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Nov. 17, 2021 (GLOBE NEWSWIRE) -- According to a new market research report titled “RWE Solutions Market by Component (Datasets [Clinical, Claims, Pharmacy, Integrated],...
Processa Pharmaceuticals to Present at “Zooming with LD Micro” Virtual Investor Event on July 29, 2021 at 12:00 p.m. ET
July 27, 2021 08:30 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, July 27, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) announced today that it will be presenting at the upcoming “Zooming with LD Micro” virtual investor event...
Processa Pharmaceuticals to Present at LD Micro Virtual Investor Conference on June 9, 2021, at 1:30pm ET
June 07, 2021 16:05 ET
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, June 07, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve...
Lumere Upgrades Product Introduction Management Platform with Spend Analytics
June 25, 2019 11:05 ET
|
Lumere
CHICAGO, June 25, 2019 (GLOBE NEWSWIRE) -- Lumere, Inc., a leading provider of evidence-based analytics and services to reduce costly and unwarranted clinical variation, today announced its Product...
Guthrie Adopts Procured Health’s Full Solution Suite to Reduce Clinical Supply Spend Across the System
July 12, 2017 07:07 ET
|
Procured Health
CHICAGO, July 12, 2017 (GLOBE NEWSWIRE) -- Guthrie, an integrated health system with subspecialty and primary care sites in 22 communities throughout Pennsylvania and New York, announced that it...